Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Cassidy James. Director active across 1 company, notably SpringWorks Therapeutics, Inc.. In total, 8 reports have been recorded. History available since 1 September 2023. The latest transaction was disclosed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
17,323 shares0Common StockSEC:0001104659-25-003461:0
4,325 shares@ US$38.1955.0% of flowCommon StockSEC:0001104659-25-001766:0
1,969 shares@ US$41.7125.4% of flowCommon StockSEC:0001104659-24-096360:0
591 shares@ US$38.537.3% of flowCommon StockSEC:0001104659-24-077347:0
28,208 shares0Common StockSEC:0001104659-24-002372:0
1,292 shares@ US$30.3312.4% of flowCommon StockSEC:0001104659-23-099291:0
5,720 sharesCommon StockSEC:0001104659-23-078086:0
22,663 sharesCommon StockSEC:0001104659-23-002320:0